🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

855 notícias encontradas para "study"
First randomized controlled trial shows promise of a ketogenic diet in psychotic disorders
First randomized controlled trial shows promise of a ketogenic diet in psychotic disorders
Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The s
US teens underestimate risks of fentanyl use, survey finds
U.S. teens are seriously underestimating how lethal the synthetic opioid fentanyl can be, a new study says. O recorte ajuda a contextualizar a pauta dentro de Fitness.
Lung transplant dramatically improves survival for patients with terminal lung cancer, stu
A landmark Northwestern Medicine study published in JAMA suggests lung transplantation can significantly extend survival in select patients with advanced lung cancer.
Reducing vehicle emissions could prevent thousands of deaths in Canada
A shift to cleaner transportation could prevent more than 3,600 premature deaths in Montreal and Toronto by reducing ultrafine particle pollution, a new study led by McGill researchers found.
People with past or current criminal legal involvement pay significantly more visits to em
People with past or current criminal legal involvement pay significantly more visits to em
People with a history of criminal legal involvement have higher odds of visiting an emergency department (ED), particularly for substance use and mental health reasons, according to a study published in PLOS One by Vidya Eswaran of Washington University in St. Louis, U.S., and co
Decline in work productivity found 15 years before early-onset dementia diagnosis
People diagnosed with early-onset dementia had reduced work productivity up to 15 years before diagnosis, according to a study published in Neurology. Researchers also found the number of years of lower productivity varied depending on the type of dementia.
Ivermectin isn't a cancer miracle drug, but influencers claim otherwise
Though researchers have been studying the animal deworming drug ivermectin for decades, there is no evidence that it's a safe or effective way to treat cancer in people.
Young women diagnosed with breast cancer within three years of childbirth may face more ag
Young women diagnosed with breast cancer within three years of childbirth may face more ag
Breast cancers diagnosed during the first three years after childbirth, particularly within the first year, may be biologically more aggressive than similar cancers in women who have never given birth, according to a new study led by investigators at the UCLA Health Jonsson Compr
Early access to a cardiac surgical hospital linked to shorter hospitalization for newborns
Congenital heart defects are the most common birth defects in the United States. For newborns with the most severe defects—those needing lifesaving intervention—later transfer to a cardiac surgical center is linked to longer hospitalization compared with those born at a surgical
Foto: Merlin Lightpainting / Pexels
Team discovers metabolic pathway in cell nucleus that helps cancer progress
A team at Roswell Park Comprehensive Cancer Center has identified a novel metabolic pathway that plays a key role in enabling cancer to progress through gene activation. In a new study published in the journal Nature Communications, the researchers show that shutting down the pat
Foto: Anna Tarazevich / Pexels
Fluoxetine, cognitive behavioral therapy, and combination beneficial for youths with anxie
For youths with anxiety disorders, similar symptom reduction is seen with fluoxetine, cognitive behavioral therapy (CBT) and their combination, according to a study published online June 24 in The American Journal of Psychiatry.
AI-guided CRISPR uncovers oxytocin receptor as unexpected psoriasis drug target
Biohub researchers have performed what they believe is the first genome-wide CRISPR study of primary human adult skin cells, then used an AI model to mine the results for overlooked drug targets for psoriasis. They found an unlikely candidate: the receptor for oxytocin, a hormone